Scientists create ‘pain-on-a-chip’ device to identify chronic pain types

Telling your doctor exactly how much something hurts has always been a challenge but Monash University researchers have developed a clever solution that could take the guesswork out of pain diagnosis. On Sunday, scientists revealed a new microfluidic device nicknamed “pain-on-a-chip” that can objectively distinguish between different types of chronic pain, such as fibromyalgia and…

UQ biotech innovation partnership forges a second startup

A new startup aimed at discovering and developing anti-inflammatory disease medicines has been formed by The University of Queensland’s commercialisation arm UniQuest and global biotech company Molecule to Medicine (MTM), according to a statement released on Tuesday. Curlew Bio will leverage expertise from the Queensland Emory and Drug Discovery Initiative (QEDDI) and research developed by…

Call for homegrown medicine production as penicillin imports dry up

A critical shortage of an essential penicillin medication is highlighting Australia’s vulnerability in pharmaceutical manufacturing, according to a new report published in the Medical Journal of Australia on Monday. The medication, benzathine benzylpenicillin G (BPG), is vital for treating syphilis and preventing rheumatic heart disease, conditions that disproportionately affect Aboriginal and Torres Strait Islander communities.…